0 items USD 0.00Search
Your search for "asia market information development co chinese markets liver cancer treatment drugs" gave back 1596702 results.
Adenosine Receptor A3 (ADORA3) - Pipeline Review, H2 2018 Summary Adenosine Receptor A3 (ADORA3) pipeline Target constitutes close to 17 molecules...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
Adenosine Receptor A3 (ADORA3) - Pipeline Review, H2 2019 Summary Adenosine Receptor A3 (ADORA3) pipeline Target constitutes close to 13 molecules...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
This study focuses on China’s Emerging Pharmaceuticals industry forecasts. In the two past decades, the industry has been growing at a fast pace. The...
Catalog:
Asia Market Information & Development Co.
June 2021
Price: USD 1,800.00
Adenosine Receptor A3 - Pipeline Review, H1 2020 Summary According to the recently published report 'Adenosine Receptor A3 - Pipeline Review, H1...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Adenosine Receptor A3 (ADORA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
July 2022
Price: USD 3,500.00
Adenosine Receptor A3 - Pipeline Review, H2 2020 Summary Adenosine Receptor A3 (ADORA3) pipeline Target constitutes close to 16 molecules. Out of...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
This study focuses on China’s Generic Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic...
Catalog:
Asia Market Information & Development Co.
October 2019
Price: USD 1,800.00
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
China's demand for Emerging Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will...
Catalog:
Asia Market Information & Development Co.
June 2021
Price: USD 4,000.00
Trans-arterial Chemoembolization (TACE) is an interventional radiology procedure that delivers anti-cancer medication (chemotherapy) and embolizing...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
